DOC · 8-K · 20261102PR068878

Guidance / Outlook

HEALTHPEAK PROPERTIES, INC. · 2026-11-02 · Importance 62 · Surprise 68 · In source text

Healthpeak raised its 2026 diluted FFO as Adjusted guidance to $1.76–$1.78 per share from $1.73–$1.77, a $0.02 increase at the midpoint. Total Same-Store Cash Adjusted NOI guidance increased 50 basis points at the midpoint, from 0%–1.5% to 0.5%–2.0%. Diluted earnings guidance fell from $0.48–$0.52 to $0.39–$0.41, a $0.10 midpoint decrease, primarily due to depreciation and amortization from Janus Living senior housing acquisitions; the company said this does not affect FFO as Adjusted guidance.

Key facts

• Healthpeak's 2026 diluted earnings per common share guidance was reduced from $0.48–$0.52 as of August 4 to $0.39–$0.41 as of November 2, a $0.10 decrease at the midpoint. source
• Healthpeak's 2026 diluted FFO as Adjusted per-share guidance increased from $1.73–$1.77 as of August 4 to $1.76–$1.78 as of November 2, a $0.02 midpoint increase. source
• Healthpeak increased its 2026 Total Same-Store Cash (Adjusted) NOI guidance from 0%–1.5% to 0.5%–2.0%, a 50-basis-point increase. source
• Healthpeak said the decrease in 2026 diluted earnings-per-share guidance primarily reflects depreciation and amortization associated with Janus Living senior housing acquisitions closed during Q3 and through October 30, 2026; the change has no impact on FFO as Adjusted guidance. source

Impact estimates